Jung Min Jo

  • Attorney
  • Partner
  • T. +82-2-3404-0167
  • F. +82-2-3404-0803
  • E. jungmin.jo@bkl.co.kr

Overview

Jung Min Jo's practice primarily focuses on healthcare and life science, mergers and acquisitions, and foreign investments. Since joining Bae, Kim & Lee LLC in 1999, Mr. Jo has advised a broad range of domestic and foreign major companies across many industries on mergers and acquisitions, joint venture, foreign investments, outbound investments and technology transactions.

Mr. Jo directs overall healthcare and life science practice and specializes in advising Korean and international clients on various legal issues affecting the health care and life science field in Korea.

Mr. Jo was a member of Advisory Committee for Revision of Commercial Law (i.e., corporate law) under the Ministry of Justice, an auditor of Korea Institute of Drug Safety and Risk Management, and a member of Self-Regulation Review Committee of the Ministry of Food and Drug Safety. In 2012, he was selected as an "External Counsel of the Year" by Asian-MENA Counsel and was also recognized one of "Best Lawyer" by Korea In-House Counsel Association in 2017.

Representative Experience

1999-Present Bae, Kim & Lee LLC
See More
2012-2018 Auditor, Korea Institute of Drug Safety and Risk Management
2012-2017 Member, Self-Regulation Review Committee, Ministry of Food and Drug Safety
2011-2014 Member, Commercial Code Amendment Committee, Ministry of Justice

Representative Matters

Advised Hanmi Pharmaceutical on patent licensing agreements with global pharmaceutical companies including Sanofi, Eli Lilly, Janssen, and Boehringer Ingelheim
Advised Yuhan Corporation on incorporation of ImmuneOncia, a joint venture for anti-cancer medicine R&D with Sorrento Therapeutics, a NASDAQ-listed pharmaceutical company
Advised GE Healthcare on acquisition of the Mammography business from Vatech
Advised Hotel Lotte on acquisition of New York Palace Hotel
Advised SBS Media Holdings on establishment of a JVC with CNBC, ESPN and MTV! and obtainment of approval
Advised Hanmi Pharmaceutical on patent licensing agreements with global pharmaceutical companies including Sanofi, Eli Lilly, Janssen, and Boehringer Ingelheim
Advised Yuhan Corporation on incorporation of ImmuneOncia, a joint venture for anti-cancer medicine R&D with Sorrento Therapeutics, a NASDAQ-listed pharmaceutical company
Advised GE Healthcare on acquisition of the Mammography business from Vatech
Advised Hotel Lotte on acquisition of New York Palace Hotel
Advised SBS Media Holdings on establishment of a JVC with CNBC, ESPN and MTV! and obtainment of approval
Advised Daewoong Pharmaceutical on due diligence and negotiation to acquire an Italian pharmaceutical company
Advised Hanmi Pharmaceutical on acquisition of JVM
Advised Hanwha S&C and Sinolending on incorporation of a Singaporean fintech JV
Advised Hanmi Pharmaceutical on investment in Spectrum Pharmaceuticals, a NASDAQ-listed pharmaceutical company
Advised Korea Post and other domestic institutional investors on acquisition of the office building of Amazon in New York and of AT&T in Chicago and Atlanta
Advised Daewoong Pharmaceutical on acquisition of Hanall Bio-Pharma
Advised Hanmi Pharmaceutical on investment in Allegro Ophthalmics, an Americal company that develops new eye medicine
Advised Yuanta Securities Asia Financial Services Limited on acquisition of Tongyang Securities
Advised Daewoong Pharmaceutical on acquisition of Baifeng, a Chinese pharmaceutical company
Advised Korea Investment Management on acquisition of equities in Parallel, an American company
Advised SBS-Viacom on incorporation of a JV
Advised Mirae Asset on acquisition of Taiwan Life Insurance asset management unit
Advised Lotte Chilsung on acquisition of a controlling stake in Pepsi-Cola Products Philippines
Advised LHSC Ltd on acquisition of equities in Lucky Pai Ltd
Advised Hotel Lotte on acquisition of AK Global
Advised Kumho Investment Bank on acquisition of AIG's headquarters
Advised Skyworks Solution onn acquisition of MEMS Solution
Advised Brenntag AG on acquisition of a local food additives company
Xerox's acquisition of certain ink jet printing assets from Hana Corporation
Advised Applied Materials on equity investment into Point Engineering and SuNAM
Advised Turner Broadcasting System on acquisition of a local channel operator and on launching of Boomerang channel
Advised Metso Automation OY on acquisition of Valstone Controls

Education

2005 Beijing Language and Culture University
2004 Columbia Law School (LL.M.)
1996 Judicial Research and Training Institute, Supreme Court of Korea
1994 Seoul National University (LL.B.)

Selected Activities

Publications
The Life Sciences Law Review Series, 1st-4th Edition (Law Business Research, 2013-2016)
Awards
Asian-MENA Counsel, Selected as External Counsel of the Year (2012)

Qualifications

1996 Korea

Related Content

View more